|
|
||||||||
Center for Health Sciences, and Laboratory of Nuclear Medicine and Radiation Biology, University of California, Los Angeles, California
Correspondence: For reprints contact: Norman D. Poe, Div. of Nuclear Medicine, UCLA Medical Center, Los Angeles, Calif. 90024.
ABSTRACT
Potassium-43 and its analog, 129Cs, have recently been suggested as suitable radiopharmaceuticals for myocardial scanning. Studies with 42K and 131Cs were undertaken in dogs to determine the myocardial turnover characteristics of these two ions. After simultaneous intravenous injection, potassium clears rapidly from the blood, reaches a plateau in the myocardium within 520 min, and then clears with a T1/2 of 6.5 hr. Initial cesium clearance is slower. A peak is reached gradually in the myocardium within 13 hr, and the clearance T1/2 is 27.3 hr. Following intracoronary injection, potassium is extracted with 71% efficiency on a single circulation, but cesium is extracted with only 22% efficiency. It is concluded that cesium should be used with caution as a substitute for potassium in quantitative myocardial blood flow and function measurements, but that comparable results can be obtained with either radionuclide in localizing ischemic myocardium.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |